Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Amphastar Pharmaceuticals (AMPH) Long-Term Debt Issuances (2016 - 2023)

Amphastar Pharmaceuticals (AMPH) has 6 years of Long-Term Debt Issuances data on record, last reported at $345.0 million in Q3 2023.

  • For Q3 2023, Long-Term Debt Issuances changed N/A year-over-year to $345.0 million; the TTM value through Dec 2023 reached $348.2 million, changed N/A, while the annual FY2023 figure was $845.0 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $345.0 million in Q3 2023 per AMPH's latest filing, up from $3.2 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $345.0 million in Q3 2023 and bottomed at $3.1 million in Q1 2020.